Clinical Trial Update: Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part I [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the safety of single doses of SAR113945. It also assessed the efficacy and safety of a new intra-articular knee formulation in pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• SAR113945

Snippet

Sponsor: Sanofi | Conditions: Knee Osteoarthritis | Phase 1 | Status: COMPLETED